Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322758083> ?p ?o ?g. }
- W4322758083 endingPage "995" @default.
- W4322758083 startingPage "981" @default.
- W4322758083 abstract "Atopic dermatitis (AD) is a chronic, inflammatory skin disorder that impairs patients' quality of life (QoL). Physician assessment of AD disease severity is determined by clinical scales and assessment of affected body surface area (BSA), which might not mirror patients' perceived disease burden.Using data from an international cross-sectional web-based survey of patients with AD and a machine learning approach, we sought to identify disease attributes with the highest impact on QoL for patients with AD. Adults with dermatologist-confirmed AD participated in the survey between July-September 2019. Eight machine learning models were applied to the data with dichotomised Dermatology Life Quality Index (DLQI) as the response variable to identify factors most predictive of AD-related QoL burden. Variables tested were demographics, affected BSA and affected body areas, flare characteristics, activity impairment, hospitalisation and AD therapies. Three machine learning models, logistic regression model, random forest and neural network, were selected on the basis of predictive performance. Each variable's contribution was computed via importance values from 0 to 100. For relevant predictive factors, further descriptive analyses were conducted to characterise those findings.In total, 2314 patients completed the survey with mean age 39.2 years (standard deviation 12.6) and average disease duration of 19 years. Measured by affected BSA, 13.3% of patients had moderate-to-severe disease. However, 44% of patients reported a DLQI > 10, indicative of a very large to extremely large impact on QoL. Activity impairment was the most important factor predicting high QoL burden (DLQI > 10) across models. Hospitalisation during the past year and flare type were also highly ranked. Current BSA involvement was not a strong predictor of AD-related QoL impairment.Activity impairment was the single most important factor for AD-related QoL impairment while current extent of AD did not predict higher disease burden. These results support the importance of considering patients' perspectives when determining the severity of AD." @default.
- W4322758083 created "2023-03-03" @default.
- W4322758083 creator A5013763025 @default.
- W4322758083 creator A5015211894 @default.
- W4322758083 creator A5020129995 @default.
- W4322758083 creator A5040210846 @default.
- W4322758083 creator A5046072430 @default.
- W4322758083 creator A5053176930 @default.
- W4322758083 creator A5081251444 @default.
- W4322758083 creator A5081456460 @default.
- W4322758083 creator A5082165528 @default.
- W4322758083 date "2023-03-02" @default.
- W4322758083 modified "2023-10-09" @default.
- W4322758083 title "Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis" @default.
- W4322758083 cites W1806722270 @default.
- W4322758083 cites W1982061770 @default.
- W4322758083 cites W2016818237 @default.
- W4322758083 cites W2030298480 @default.
- W4322758083 cites W2063465557 @default.
- W4322758083 cites W2074749048 @default.
- W4322758083 cites W2086325363 @default.
- W4322758083 cites W2087624875 @default.
- W4322758083 cites W2090735611 @default.
- W4322758083 cites W2096991001 @default.
- W4322758083 cites W2146302565 @default.
- W4322758083 cites W2146648821 @default.
- W4322758083 cites W2556974831 @default.
- W4322758083 cites W2623278488 @default.
- W4322758083 cites W2744776760 @default.
- W4322758083 cites W2760088364 @default.
- W4322758083 cites W2763454449 @default.
- W4322758083 cites W2784010902 @default.
- W4322758083 cites W2807010662 @default.
- W4322758083 cites W2820763047 @default.
- W4322758083 cites W2883568898 @default.
- W4322758083 cites W2899071879 @default.
- W4322758083 cites W2909953525 @default.
- W4322758083 cites W2912193282 @default.
- W4322758083 cites W2938364150 @default.
- W4322758083 cites W2969216821 @default.
- W4322758083 cites W2978453992 @default.
- W4322758083 cites W2980244762 @default.
- W4322758083 cites W3014318280 @default.
- W4322758083 cites W3027152065 @default.
- W4322758083 cites W3092024349 @default.
- W4322758083 cites W3098648594 @default.
- W4322758083 cites W3102753820 @default.
- W4322758083 cites W3122709652 @default.
- W4322758083 cites W3126885798 @default.
- W4322758083 cites W3196372294 @default.
- W4322758083 cites W4211026773 @default.
- W4322758083 cites W4220683132 @default.
- W4322758083 doi "https://doi.org/10.1007/s13555-023-00897-0" @default.
- W4322758083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36862306" @default.
- W4322758083 hasPublicationYear "2023" @default.
- W4322758083 type Work @default.
- W4322758083 citedByCount "0" @default.
- W4322758083 crossrefType "journal-article" @default.
- W4322758083 hasAuthorship W4322758083A5013763025 @default.
- W4322758083 hasAuthorship W4322758083A5015211894 @default.
- W4322758083 hasAuthorship W4322758083A5020129995 @default.
- W4322758083 hasAuthorship W4322758083A5040210846 @default.
- W4322758083 hasAuthorship W4322758083A5046072430 @default.
- W4322758083 hasAuthorship W4322758083A5053176930 @default.
- W4322758083 hasAuthorship W4322758083A5081251444 @default.
- W4322758083 hasAuthorship W4322758083A5081456460 @default.
- W4322758083 hasAuthorship W4322758083A5082165528 @default.
- W4322758083 hasBestOaLocation W43227580831 @default.
- W4322758083 hasConcept C126322002 @default.
- W4322758083 hasConcept C142052008 @default.
- W4322758083 hasConcept C142724271 @default.
- W4322758083 hasConcept C144024400 @default.
- W4322758083 hasConcept C149923435 @default.
- W4322758083 hasConcept C151956035 @default.
- W4322758083 hasConcept C159110408 @default.
- W4322758083 hasConcept C16005928 @default.
- W4322758083 hasConcept C2776173921 @default.
- W4322758083 hasConcept C2777501473 @default.
- W4322758083 hasConcept C2778329239 @default.
- W4322758083 hasConcept C2779134260 @default.
- W4322758083 hasConcept C2779951463 @default.
- W4322758083 hasConcept C2780084366 @default.
- W4322758083 hasConcept C71924100 @default.
- W4322758083 hasConceptScore W4322758083C126322002 @default.
- W4322758083 hasConceptScore W4322758083C142052008 @default.
- W4322758083 hasConceptScore W4322758083C142724271 @default.
- W4322758083 hasConceptScore W4322758083C144024400 @default.
- W4322758083 hasConceptScore W4322758083C149923435 @default.
- W4322758083 hasConceptScore W4322758083C151956035 @default.
- W4322758083 hasConceptScore W4322758083C159110408 @default.
- W4322758083 hasConceptScore W4322758083C16005928 @default.
- W4322758083 hasConceptScore W4322758083C2776173921 @default.
- W4322758083 hasConceptScore W4322758083C2777501473 @default.
- W4322758083 hasConceptScore W4322758083C2778329239 @default.
- W4322758083 hasConceptScore W4322758083C2779134260 @default.
- W4322758083 hasConceptScore W4322758083C2779951463 @default.
- W4322758083 hasConceptScore W4322758083C2780084366 @default.
- W4322758083 hasConceptScore W4322758083C71924100 @default.